Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $552.68 USD
Change Today -0.98 / -0.18%
Volume 440.9K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 3:26 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - REGENERON PHARMACEUTICALS (REGN)

Regeneron Pharmaceuticals, Inc. to Report Q2, 2015 on Aug 04, 2015
CapIQ 08/04/2015 1:00 PM ET
Regeneron Pharmaceuticals, Inc. to Report Q1, 2015 on May 07, 2015
CapIQ 08/04/2015 1:00 PM ET
Regeneron Pharmaceuticals, Inc. to Report Q4, 2014 on Feb 10, 2015
CapIQ 08/04/2015 1:00 PM ET

2013 revenues at Regeneron Pharmaceuticals, Inc. totaled $2.1B USD, while annual earnings equaled $8.17 per share.

Quarterly Earnings & Estimates - REGENERON PHARMACEUTICALS (REGN)

Actuals vs. Estimates for REGENERON PHARMACEUTICALS REGN

Regeneron Pharmaceuticals, Inc.'s Quarterly Earnings

Regeneron Pharmaceuticals, Inc. reported 2nd quarter 2014 earnings of $2.47 per share on 08/7/2014.

Annual Earnings & Estimates - REGENERON PHARMACEUTICALS (REGN)

Actuals vs. Estimates for REGENERON PHARMACEUTICALS REGN

Regeneron Pharmaceuticals, Inc.'s Annual Earnings

Regeneron Pharmaceuticals, Inc. reported annual 2013 earnings of $8.17 per share on 02/13/2014.

Quarterly Revenues - REGENERON PHARMACEUTICALS (REGN)

Actuals vs. Estimates for REGENERON PHARMACEUTICALS REGN

Regeneron Pharmaceuticals, Inc.'s Quarterly Revenues

Regeneron Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $665.7M USD. This bettered the $645.5M USD consensus of the 17 analysts covering the company. This was 45.5% above the prior year's 2nd quarter results.

Annual Revenues - REGENERON PHARMACEUTICALS (REGN)

Actuals vs. Estimates for REGENERON PHARMACEUTICALS REGN

Regeneron Pharmaceuticals, Inc.'s Annual Revenues

Regeneron Pharmaceuticals, Inc. had revenues for the full year 2013 of $2.1B USD. This was 52.7% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $552.68 USD -0.98

REGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $146.15 USD -0.12
Incyte Corp $103.99 USD -0.29
Kyowa Hakko Kirin Co Ltd ¥2,051 JPY +33.00
UCB SA €71.80 EUR +1.34
Vertex Pharmaceuticals Inc $136.93 USD +1.93
View Industry Companies
 

Industry Analysis

REGN

Industry Average

Valuation REGN Industry Range
Price/Earnings 100.0x
Price/Sales 18.5x
Price/Book 19.0x
Price/Cash Flow 160.7x
TEV/Sales 18.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.